HAVCR2 and hepatocellular carcinoma: In Acute/Cirrhosis/HBsAg_high/NAFL_HCC, the expression of CTLA-4 and TIM-3 on CD4+/CD8+ T cells was inhibited instead (Fig. 4A and C).